Tounjian Advisory Partners’s Elevance Health ELV Stock Holding History

Tounjian Advisory Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.2K	Buy	+57	New	+$21.1K	0.01%	299

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Tounjian Advisory Partners's ELV Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in Elevance Health (ELV) in Q2 2026: 57 shares worth $22.2K. The stake represents 0.01% of the portfolio and ranks #299 among its holdings.

990 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Tounjian Advisory Partners held 57 shares of Elevance Health worth $22.2K as of Q2 2026.
Elevance Health was a new Tounjian Advisory Partners position in Q2 2026.
Elevance Health made up 0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #299 holding.
990 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.